Skip to main content
Journal ArticleOPEN ACCESS

Phosphodiesterase 4 inhibitors for psoriatic arthritis

Cochrane Database of Systematic Reviews (2016) 2016(10)
DOI: 10.1002/14651858.CD012401
1Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the benefits and harms of PDE4 inhibitors (e.g., apremilast) for the treatment of PsA.

Cite

CITATION STYLE

APA

Zamora, N. V., Valerio-Morales, I. A., Lopez-Olivo, M. A., Pan, X., & Suarez-Almazor, M. E. (2016). Phosphodiesterase 4 inhibitors for psoriatic arthritis. Cochrane Database of Systematic Reviews, 2016(10). https://doi.org/10.1002/14651858.CD012401

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free